To learn about our efforts to improve the accessibility and usability of our website, please visit our Accessibility Information page. Skip to section navigation or Skip to main content
Below is an advertisement.
  • mlb.im.tv
  • mlb.com/japan
  • LasMayores.com
Shop for Batting Practice Caps
|
|
|
|
|
|
|
|
|
|
|
|

Community

Skip to main content
  • Boys and Girls Clubs of America
Below is an advertisement.

"For the past two weeks you have been reading about a bad break I got. Yet today I consider myself the luckiest man on the face of the earth." – Lou Gehrig July 4, 1939

PHILADELPHIA -- One of the greatest players in Major League Baseball history was struck down nearly 70 years ago by amyotrophic lateral sclerosis, and ever since then the disease has been synonymous with the name of Lou Gehrig.

Major League Baseball is dedicating Monday night's Game 5 of the 105th World Series to its ongoing 4♦ALS Awareness initiative as a tribute not only to Gehrig, but also to the lifelong baseball fan who inspired MLB to make everyone aware of the disease that claimed his own life on Sunday.

Michael Goldsmith died at age 58 after battling ALS for three years. He passed away in a hospice at St. Peter's Hospital in Albany, where he had been living since early August, according to his surviving family. The cause of death was respiratory failure from ALS, which is a progressive disease that destroys the nerve cells controlling voluntary muscle movement. Read More >

< Back
Next >


ALS ASSOCIATION

The ALS Association is a leader in the fight against ALS through global research, compassionate care and support, and advocacy.
Click here >

MDA/AUGIE'S QUEST

Since it began its ALS program with Eleanor Gehrig in the early 1950s, MDA has expended $250 million on ALS services and research.
Click here >

ALS TDI

ALS TDI, the world's largest ALS research center and non-profit biotech, is devoted to developing therapeutics to stop Lou Gehrig's disease.
Click here >

Project A.L.S.

Since 1998, Project A.L.S. has been a catalyst and a leader in the effort to identify and develop the first effective treatments for ALS.
Click here >